PAUL DIEHL: Open Payments
NPI 1336215607 · WEST HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 13 payments from 6 companies in 2025. Trend: 2023 $329 · 2024 $635 · 2025 $305
Food & beverage: $305
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $177 |
| Novo Nordisk Inc | 2 | $41 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| TOLMAR, INC. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Almatica Pharma LLC | 1 | $17 |
Products named: VRAYLAR, TRELEGY ELLIPTA, Ozempic, JATENZO, LEQVIO, LOREEV XR, Rybelsus.
Industry payments across CA — which companies pay providers there.
